Landos Biopharma

+$0.16 (+1.50%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LABP and other stocks, options, and ETFs commission-free!

About LABP

Landos Biopharma, Inc. engages in the development and commercialization of novel therapeutics for autoimmune diseases. The firm offers BT-11, a novel, oral, gut-restricted therapeutic candidate for the treatment of ulcerative colitis and Crohn’s disease that targets the LANCL2 pathway.

CEO
Josep Bassaganya-Riera
Employees
33
Headquarters
Blacksburg, Virginia
Founded
2017

LABP Key Statistics

Market Cap
451.69M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
62.97K
High Today
$11.07
Low Today
$10.40
Open Price
$10.78
Volume
67.31K
52 Week High
$16.99
52 Week Low
$8.82

LABP Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 8, Pre-Market

You May Also Like

HRTG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure